Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease

被引:85
|
作者
Fernandez-Prado, Raul [1 ]
Esteras, Raquel [1 ]
Vanessa Perez-Gomez, Maria [1 ]
Gracia-Iguacel, Carolina [1 ]
Gonzalez-Parra, Emilio [1 ]
Sanz, Ana B. [1 ]
Ortiz, Alberto [1 ]
Dolores Sanchez-Nino, Maria [1 ]
机构
[1] Univ Autonoma Madrid, Fdn Jimenez Diaz, IIS, Madrid 28040, Spain
关键词
chronic kidney disease; caramboxin; microbiota; choline; carnitine; tryptophan; tyrosine; trimethylamine N-Oxide (TMAO); p-cresyl sulfate; indoxyl sulfate; gut-kidney axis; TRIMETHYLAMINE-N-OXIDE; P-CRESYL SULFATE; ARYL-HYDROCARBON RECEPTOR; BOUND UREMIC TOXINS; PLASMA CHOLINE CONCENTRATIONS; ORAL L-CARNITINE; INDOXYL SULFATE; GUT MICROBIOTA; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR-DISEASE;
D O I
10.3390/nu9050489
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
In chronic kidney disease (CKD), accumulation of uremic toxins is associated with an increased risk of death. Some uremic toxins are ingested with the diet, such as phosphate and star fruit-derived caramboxin. Others result from nutrient processing by gut microbiota, yielding precursors of uremic toxins or uremic toxins themselves. These nutrients include L-carnitine, choline/phosphatidylcholine, tryptophan and tyrosine, which are also sold over-the-counter as nutritional supplements. Physicians and patients alike should be aware that, in CKD patients, the use of these supplements may lead to potentially toxic effects. Unfortunately, most patients with CKD are not aware of their condition. Some of the dietary components may modify the gut microbiota, increasing the number of bacteria that process them to yield uremic toxins, such as trimethylamine N-Oxide (TMAO), p-cresyl sulfate, indoxyl sulfate and indole-3 acetic acid. Circulating levels of nutrient-derived uremic toxins are associated to increased risk of death and cardiovascular disease and there is evidence that this association may be causal. Future developments may include maneuvers to modify gut processing or absorption of these nutrients or derivatives to improve CKD patient outcomes.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease
    Meijers, B.
    Jouret, F.
    Evenepoel, P.
    PHARMACOLOGICAL RESEARCH, 2018, 133 : 101 - 107
  • [22] The modulation effects of plant-derived bioactive ingredients on chronic kidney disease: Focus on the gut-kidney axis
    Jian, Shiyan
    Yang, Kang
    Zhang, Lingna
    Zhang, Limeng
    Xin, Zhongquan
    Wen, Chaoyu
    He, Shansong
    Deng, Jinping
    Deng, Baichuan
    FOOD FRONTIERS, 2023, 4 (01): : 262 - 282
  • [23] The clinical impact of gut microbiota in chronic kidney disease
    Kim, So Mi
    Song, Il Han
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (06) : 1305 - 1316
  • [24] Alterations of intestinal barrier and microbiota in chronic kidney disease
    Sabatino, Alice
    Regolisti, Giuseppe
    Brusasco, Irene
    Cabassi, Aderville
    Morabito, Santo
    Fiaccadori, Enrico
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (06) : 924 - 933
  • [25] Gut microbiota generation of protein -bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease see
    Gryp, Tessa
    De Paepe, Kim
    Vanholder, Raymond
    Kerckhof, Frederiek-Maarten
    Van Biesen, Wim
    Van de Wiele, Tom
    Verbeke, Francis
    Speeckaert, Marijn
    Joossens, Marie
    Couttenye, Marie Madeleine
    Vaneechoutte, Mario
    Glorieux, Griet
    KIDNEY INTERNATIONAL, 2020, 97 (06) : 1230 - 1242
  • [26] Cardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney Disease
    Moradi, Hamid
    Sica, Domenic A.
    Kalantar-Zadeh, Kamyar
    AMERICAN JOURNAL OF NEPHROLOGY, 2013, 38 (02) : 136 - 148
  • [27] Gut Microbiota in Chronic Kidney Disease: From Composition to Modulation towards Better Outcomes-A Systematic Review
    Voroneanu, Luminita
    Burlacu, Alexandru
    Brinza, Crischentian
    Covic, Andreea
    Balan, Gheorghe G.
    Nistor, Ionut
    Popa, Cristina
    Hogas, Simona
    Covic, Adrian
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [28] Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease
    Addi, Tawfik
    Dou, Laetitia
    Burtey, Stephane
    TOXINS, 2018, 10 (10)
  • [29] Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: An observational study
    Rossi, M.
    Campbell, K.
    Johnson, D.
    Stanton, T.
    Pascoe, E.
    Hawley, C.
    Dimeski, G.
    McWhinney, B.
    Ungerer, J.
    Isbel, N.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (09) : 1035 - 1042
  • [30] Link between gut microbiota dysbiosis and chronic kidney disease
    Noce, A.
    Marchetti, M.
    Marrone, G.
    Di Renzo, L.
    Di Lauro, M.
    Di Daniele, F.
    Albanese, M.
    Di Daniele, N.
    De Lorenzo, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (06) : 2057 - 2074